CO2020001342A2 - Composición que contiene cannabinoides con biodisponibilidad mejorada - Google Patents

Composición que contiene cannabinoides con biodisponibilidad mejorada

Info

Publication number
CO2020001342A2
CO2020001342A2 CONC2020/0001342A CO2020001342A CO2020001342A2 CO 2020001342 A2 CO2020001342 A2 CO 2020001342A2 CO 2020001342 A CO2020001342 A CO 2020001342A CO 2020001342 A2 CO2020001342 A2 CO 2020001342A2
Authority
CO
Colombia
Prior art keywords
cannabinoids
composition containing
components
improved bioavailability
containing cannabinoids
Prior art date
Application number
CONC2020/0001342A
Other languages
English (en)
Inventor
Wernli Miriam Halperin
Jorge Wernli
Gian Batista Trepp
Silvia Huber
Franco Madea
Original Assignee
Creso Pharma Switzerland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creso Pharma Switzerland Gmbh filed Critical Creso Pharma Switzerland Gmbh
Publication of CO2020001342A2 publication Critical patent/CO2020001342A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/235—Foeniculum (fennel)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Una composición alimenticia o nutricional o dietética o un suplemento alimenticio o nutricional o dietético adecuado para el suministro bucal de cannabinoides comprende una fuente de cannabinoides en combinación con un agente vasodilatador seleccionado de aceites esenciales o componentes de los mismos, sabores o componentes de los mismos y especias o componentes de las mismas. La fuente preferida de cannabinoides es el aceite estandarizado o el extracto de cáñamo (Cannabis sativa L.).
CONC2020/0001342A 2017-08-08 2020-02-06 Composición que contiene cannabinoides con biodisponibilidad mejorada CO2020001342A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762542459P 2017-08-08 2017-08-08
PCT/IB2018/000862 WO2019030561A1 (en) 2017-08-08 2018-08-07 COMPOSITION CONTAINING CANNABINOIDS HAVING ENHANCED BIOAVAILABILITY

Publications (1)

Publication Number Publication Date
CO2020001342A2 true CO2020001342A2 (es) 2020-02-18

Family

ID=63517923

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2020/0001342A CO2020001342A2 (es) 2017-08-08 2020-02-06 Composición que contiene cannabinoides con biodisponibilidad mejorada

Country Status (7)

Country Link
US (1) US20200230185A1 (es)
EP (1) EP3664825A1 (es)
AU (1) AU2018315696A1 (es)
BR (1) BR112020001763A2 (es)
CA (1) CA3069887A1 (es)
CO (1) CO2020001342A2 (es)
WO (1) WO2019030561A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
EP3864000A4 (en) 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. CANNABIGEROL SYNTHESIS
US20210212950A1 (en) * 2020-01-15 2021-07-15 Resurgent Pharmaceuticals, Inc. Orally deliverable formulation to prevent all cause mortality and cardiovascular events

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2499785A1 (en) 2004-04-05 2005-10-05 Covolam Decorative paneling system for wall and method of instalation
US20140166027A1 (en) 2012-12-14 2014-06-19 Richard C. Fuisz Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor Producing Device Through Use of an Absorption Conditioning Unit
WO2016014454A1 (en) * 2014-07-21 2016-01-28 Pharmaceutical Productions, Inc. Solid dosage form composition for buccal or sublingual administration of cannabinoids
US20160058866A1 (en) 2014-09-02 2016-03-03 Ronald D. Sekura Alternative solutions for the administration of cannabis derived botanical products
WO2017072774A1 (en) * 2015-10-29 2017-05-04 Solubest Ltd Pharmaceutical compositions for transmucosal delivery
CN105341185A (zh) * 2015-11-11 2016-02-24 成都圣弘源生物科技有限公司 一种复合营养调和油及其制备方法

Also Published As

Publication number Publication date
CA3069887A1 (en) 2019-02-14
US20200230185A1 (en) 2020-07-23
AU2018315696A1 (en) 2020-02-06
BR112020001763A2 (pt) 2020-07-21
EP3664825A1 (en) 2020-06-17
WO2019030561A1 (en) 2019-02-14

Similar Documents

Publication Publication Date Title
CO2020001342A2 (es) Composición que contiene cannabinoides con biodisponibilidad mejorada
MX2019000427A (es) Formas de dosificacion oral de cannabinoide de alta concentracion.
CL2017002335A1 (es) Composiciones de cosmetica topica para combatir radicales libres
MX2019002198A (es) Composiciones solubles en agua que comprenden cannabinoides purificadas.
MX2020007784A (es) Uso de cannabinoides en el tratamiento de la epilepsia.
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
CO2019000787A2 (es) Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración
GT201000174A (es) Polvo nutricional estable
CO2019001043A2 (es) Composición de cannabis
BR112019018088A2 (pt) Composições propositadamente selecionadas que compreendem canabinoides purificados e/ou terpenos purificados
CL2020003368A1 (es) Composicion y metodo para tratar el dolor
CR20170356A (es) Composiciones farmacéuticas para terapia combinada
AR100562A1 (es) Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
CO2020000111A2 (es) Composición de gránulos veterinarios que contiene extracto de cáñamo
BR112018070060A2 (pt) composições para tratamento bucal com uma exibição de sabor eficiente
ES2540403R2 (es) Recubrimiento comestible para la conservación de trozos de fruta, su proceso de fabricación y de aplicación
AR110060A1 (es) Composiciones nutricionales que proporcionan el manejo dietético de cólicos
MX2022007557A (es) Formulaciones orales de cannabinoides.
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
DOP2021000182A (es) Composiciones, preparacion y usos de paramilo
CL2015003798A1 (es) Composición natural antioxidante y antibacteriana, elaborada a partir de extractos fenolicos de aristotelia chilensis y procesos de obtención.
CR20110500A (es) Composición nutricional que comprende curcuminoides y métodos para fabricarla
CL2016000047A1 (es) Productos de confitería a base de grasa.
ES2531412T3 (es) Composición nutricional que comprende un extracto de manzana y que reduce los síntomas de alergia, especialmente en niños
BR112018001295A2 (pt) ?uso combinado de pelo menos um derivado de molibdênio e pelo menos um derivado de boro e uso de uma combinação de pelo menos um derivado de molibdênio e pelo menos um derivado de boro?